Passionate about innovation, I have dedicated my professional life to find disruptive ways to prevent cancer, making an impact on people´s lives through early diagnostics. CEO of Amadix, the first Global Winner of South Summit in the healthcare field. It is a disruptive biotech company in the liquid biopsy space, focused on early cancer detection in blood, before the symptoms appear, to extend people´s lives. We develop technologies to detect colon, pancreatic and lung cancer in blood, a few years before the tumor appears, in healthy individuals with no symptoms. Extensive pharmaceutical, biotechnology, and public/private health-sector knowledge.